Health
South African virus mutation raises questions over vaccine effectiveness – The Times of Israel
Scientists express concern over E484K strain, which Cambridge microbiologist warns ‘could be the start of problems for spike vaccines’ developed by Pfizer, Moderna…
PARIS (AFP) — As the British coronavirus variant occupies countries’ pandemic plans due to its increased transmissibility, other mutations to the Sars-CoV-2 are provoking concern among scientists who are scrambling to work out if they will respond to vaccines.
In particular, one mutation, known as E484K, detected initially in South Africa and on subsequent variants in Brazil and Japan, has raised alarm among researchers.
Ravi Gupta, professor of microbiology at the University of Cambridge, said…
-
General17 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
General12 hours agoStephanie Scott’s murder caused a ‘seismic’ shock in Leeton, and the hurt remains
-
Noosa News23 hours agoStudents say new facility would be better in rural areas of Queensland